Launching Global Clinical Trials (whitepaper)

Best Practices for Efficient and Cost-Effective Translations

According to Thompson CenterWatch, 20 to 30 percent of clinical trials are being conducted in the ascending regions – India, China and Russia – due in large part to benefits such as:

• access to large, drug-naïve populations
• lower trial operating costs
• the ability to rapidly recruit suitable participants

This focus on end-benefits, however, fails to consider the deep challenges of the launch process itself, and companies who are not yet globally-proficient are likely to underestimate the critical role translation plays in that effort.

This Lionbridge white paper offers an experience-based overview of the global clinical trials translation process, including:

• issues and challenges of global trial communication
• planning for translation
• best practices for clinical trials translation

Download the Whitepaper (pdf, English)